Verition Fund Management
ARRY

Verition Fund Management’s Array Biopharma Inc ARRY Stock Holding History

Verition Fund Management’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-17,505
Closed -$286K – 1450
2018
Q1 		$286K Buy
+17,505
New +$280K 0.02% 848
2017
Q3 		– Sell
-41,333
Closed -$346K – 1463
2017
Q2 		$346K Buy
+41,333
New +$338K 0.03% 612
2014
Q3 		– Sell
-12,363
Closed -$56K – 929
2014
Q2 		$56K Buy
+12,363
New +$51.1K 0.01% 627
2014
Q1 		– Sell
-20,513
Closed -$103K – 691
2013
Q4 		$103K Buy
+20,513
New +$112K 0.02% 443

Other funds holding ARRY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Verition Fund Management's ARRY Position: Q2 2018 in Review

Verition Fund Management sold out of Array Biopharma Inc (ARRY) in Q2 2018, closing a stake of 17,505 shares — an estimated $286K sold.

Verition Fund Management first reported a position in ARRY in Q4 2013 and held it in 4 quarters. The position peaked at $346K in Q2 2017. 223 funds tracked by Wall St. Rank hold ARRY as of Q2 2018.

  • Verition Fund Management reported no remaining Array Biopharma Inc position as of Q2 2018 after selling out during the quarter.
  • Verition Fund Management sold 17,505 Array Biopharma Inc shares in Q2 2018, an estimated $286K.
  • Verition Fund Management first reported a position in Array Biopharma Inc in Q4 2013 and held it in 4 quarters.
  • Verition Fund Management's Array Biopharma Inc position peaked at $346K in Q2 2017.
  • 223 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q2 2018.

Based on Verition Fund Management's 13F filing for Q2 2018, filed 15 Aug 2018.